Trade

with

United Therapeutics Corp
(NASDAQ: UTHR)
AdChoices
129.00
+1.39
+1.09%
After Hours :
128.97
-0.03
-0.02%

Open

127.73

Previous Close

127.61

Volume (Avg)

703.01k (923.30k)

Day's Range

126.98-131.44

52Wk Range

81.26-136.93

Market Cap.

6.03B

Dividend Rate ( Yield )

-

Beta

1.37

Shares Outstanding

47.27M

P/E Ratio (EPS)

24.69 (5.17)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Biotechnology
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 1.12B

    • Net Income

    • 174.56M

    • Market Cap.

    • 6.03B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 23.41

    • PEG (Price/Earnings Growth) Ratio

    • 0.09

    • Beta

    • 1.37

    • Forward P/E

    • 9.03

    • Price/Sales

    • 5.78

    • Price/Book Value

    • 5.14

    • Price/Cash flow

    • 22.68

      • EBITDA

      • 328.22M

      • Return on Capital %

      • 15.10

      • Return on Equity %

      • 24.09

      • Return on Assets %

      • 15.10

      • Book Value/Share

      • 24.83

      • Shares Outstanding

      • 47.27M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 130.33

        • Credit Rating

        • -

        • Analysts

        • 5

        • EPS Estimate

        • 13.65

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 15.00

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -42.70

          • 17.04

          • Net Income

            Q/Q (last year)

          • 40.10

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • 31.74

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 88.47

            • 82.75

            • Pre-Tax Margin

            • 37.87

            • 39.38

            • Net Profit Margin

            • 23.41

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • 87.80

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 28.60

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • 20.20

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.76

              • Current Ratio

              • 1.34

              • 2.92

              • Quick Ratio

              • 1.18

              • 2.35

              • Interest Coverage

              • 25.69

              • 38.02

              • Leverage Ratio

              • 1.66

              • 2.21

              • Book Value/Share

              • 24.83

              • 4.75

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 24.10

                • 277.78

                • P/E Ratio 5-Year High

                • 26.49

                • 634.30

                • P/E Ratio 5-Year Low

                • 7.07

                • 124.82

                • Price/Sales Ratio

                • 5.65

                • 9.35

                • Price/Book Value

                • 5.02

                • 8.50

                • Price/Cash Flow Ratio

                • 22.68

                • 50.25

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 24.09

                    (17.20)

                  • 37.63

                    (27.20)

                  • Return on Assets %

                    (5-Year Average)

                  • 15.10

                    (10.80)

                  • 17.22

                    (13.81)

                  • Return on Capital %

                    (5-Year Average)

                  • 20.13

                    (12.10)

                  • 21.78

                    (17.31)

                  • Income/Employee

                  • 399.08k

                  • 117.08k

                  • Inventory Turnover

                  • 2.70

                  • 1.48

                  • Asset Turnover

                  • 0.65

                  • 0.55

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  292.50M
                  Operating Margin
                  26.19
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  22.68
                  Ownership

                  Institutional Ownership

                  -

                  Top 10 Institutions

                  42.70%

                  Mutual Fund Ownership

                  52.60%

                  Float

                  73.91%

                  5% / Insider Ownership

                  0.08%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Fidelity® Ser Intrinsic Opportunities Fd

                  •  

                    1,250,000

                  • 13.64

                  • 2.64

                  • Fidelity® Select Biotechnology Portfolio

                  •  

                    1,068,109

                  • 0.00

                  • 2.26

                  • Vanguard Small Cap Index

                  •  

                    780,028

                  • 3.66

                  • 1.65

                  • BlackRock Capital Appreciation Fund

                  •  

                    754,388

                  • 30.36

                  • 1.60

                  • Vanguard Total Stock Mkt Idx

                  •  

                    732,013

                  • 4.18

                  • 1.55

                  • iShares Core S&P Mid-Cap (AU)

                  •  

                    646,072

                  • -0.36

                  • 1.34

                  • iShares Nasdaq Biotechnology

                  •  

                    626,729

                  • -0.69

                  • 1.30

                  • Vanguard Small Cap Growth Index Fund

                  •  

                    527,228

                  • 1.63

                  • 1.12

                  • T. Rowe Price Health Sciences Fund

                  •  

                    482,243

                  • -0.29

                  • 1.02

                  • Vanguard Extended Market Index Fund

                  •  

                    433,888

                  • 5.52

                  • 0.92

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Fidelity Management and Research Company

                  •  

                    4,491,678

                  • -22.31%

                  • 9.51

                  • Vanguard Group, Inc.

                  •  

                    2,829,053

                  • -5.17%

                  • 5.99

                  • ARONSON+JOHNSON+ORTIZ

                  •  

                    2,060,960

                  • -4.51%

                  • 4.36

                  • BlackRock Fund Advisors

                  •  

                    1,922,189

                  • -3.09%

                  • 4.07

                  • LSV Asset Management

                  •  

                    1,895,328

                  • +8.64%

                  • 4.01

                  • Acadian Asset Management LLC

                  •  

                    1,881,783

                  • +0.53%

                  • 3.98

                  • State Street Corp

                  •  

                    1,383,686

                  • -3.21%

                  • 2.93

                  • TimesSquare Capital Management, LLC

                  •  

                    1,308,900

                  • +94.95%

                  • 2.77

                  • Palo Alto Investors, LLC

                  •  

                    1,213,828

                  • -44.88%

                  • 2.57

                  • BlackRock Advisors LLC

                  •  

                    1,187,031

                  • -27.81%

                  • 2.51

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Biotechnology

                  Type

                  Aggressive Growth

                  Style

                  Mid Core

                  United Therapeutics Corp was incorporated in Delaware in June 1996. The Company is a biotechnology company, which is focused on the development and commercialization of products to address the medical needs of patients with chronic a...morend life-threatening conditions. The Company operates in two business segments: pharmaceuticals and telemedicine. The pharmaceutical segment includes all activities associated with the research, development, manufacturing and commercialization of its therapeutic products. The telemedicine segment includes all activities associated with the development and manufacturing of patient cardiac monitoring products and services. Its therapeutic products include: Prostacyclin analogues (Remodulin®, Tyvaso®, Orenitram™, 314d, TransCon treprostinil and TransCon beraprost), Phosphodi...moreesterase type 5 (PDE-5) inhibitor (Adcirca®), Monoclonal antibody for oncologic applications, Glycobiology antiviral agents, Cell-based therapy, and Lung transplantation. The Company competes with the developers, manufacturers and distributors of all of these products for customers, funding, access to licenses, personnel, third-party collaborators, product development and commercialization.lessless

                  Key People

                  Martine A. Rothblatt,PhD,M.B.A.,J.D.

                  CEO/Chairman of the Board/Director/Founder

                  Christopher Patusky,J.D.

                  Director/Vice Chairman of the Board

                  John M. Ferrari

                  CFO/Chief Accounting Officer/Treasurer

                  Paul A. Mahon,J.D.

                  Executive VP/General Counsel/Secretary

                  Raymond Dwek,F.R.S.

                  Director

                  • United Therapeutics Corp

                  • 1040 Spring Street

                  • Silver Spring, MD 20910

                  • USA.Map

                  • Phone: +1 301 608-9292

                  • Fax: +1 301 608-9291

                  • unither.com

                  Incorporated

                  1996

                  Employees

                  706

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: